Kathleen Moore
MD
Director, Oklahoma TSET Phase I Program
👥Biography 个人简介
Kathleen Moore led the PRIMA trial demonstrating niraparib front-line maintenance benefit regardless of biomarker status in ovarian cancer. She has also led key trials of mirvetuximab soravtansine in folate-receptor-alpha positive disease. Her work is central to current ovarian cancer treatment algorithms.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Kathleen Moore 的研究动态
Follow Kathleen Moore's research updates
留下邮箱，当我们发布与 Kathleen Moore（Stephenson Cancer Center, University of Oklahoma）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment